Featured Archives - Page 19 of 32 - Boston Life Sciences Times

Iterative Health Raises $77 Million to Expand Clinical Research Network

April 30, 2026

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

April 28, 2026

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

April 27, 2026

THIS WEEK'S STORIES

Verastem Oncology Launches Campaign for KRAS-Mutated Recurrent Ovarian Cancer Treatment

April 30, 2026

VectorY Therapeutics Cleared to Expand ALS Clinical Trial to Europe and U.K.

April 28, 2026

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

April 30, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Featured

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

908 Devices Names Kola Otitoju Chief Business & Strategy Officer, Announces Inducement Grant

Bicycle Therapeutics Reports Promising Cancer Drug Data at AACR Meeting

Most Read

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

Verastem Oncology Launches Campaign for KRAS-Mutated Recurrent Ovarian Cancer Treatment

VectorY Therapeutics Cleared to Expand ALS Clinical Trial to Europe and U.K.

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

POPULAR CATEGORY

ABOUT US

FOLLOW US